Effects of nelfinavir and its M8 metabolite on lymphocyte P-glycoprotein activity during antiretroviral therapy.

Author: BeckerMark, DonahueJohn P, DowdyDavid, HaasDavid W, HulganTodd, NicoteraJanet, PriceJames, RaffantiSteven, RatnamKrishna K, UnutmazDerya

Paper Details 
Original Abstract of the Article :
The efflux pump P-glycoprotein decreases drug penetration into cells and tissues. To determine whether nelfinavir or its metabolites inhibit P-glycoprotein in lymphocytes from a healthy volunteer, whole blood cells from human immunodeficiency virus-negative donors were incubated either in human plas...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/12545146

データ提供:米国国立医学図書館(NLM)

Navigating the Drug Landscape: Understanding the Role of P-Glycoprotein

[P-glycoprotein] is a crucial player in drug transport and metabolism. This study investigates the impact of [nelfinavir] and its [M8 metabolite] on P-glycoprotein activity in [lymphocytes] from patients undergoing [antiretroviral therapy]. Imagine a bustling port city, where various ships carrying different goods navigate a complex network of waterways. In this case, the port city represents the human body, and P-glycoprotein acts as a gatekeeper, controlling the movement of drugs and other molecules.

The Gatekeeper's Influence: P-Glycoprotein's Impact on Drug Efficacy

The study reveals that nelfinavir and its M8 metabolite can inhibit P-glycoprotein activity in lymphocytes, potentially influencing the effectiveness of antiretroviral therapy. It's like a group of ships encountering a strong current, influencing their ability to navigate the waterways. The study emphasizes the importance of understanding the interplay between drugs and P-glycoprotein in optimizing treatment outcomes.

A Complex Network: Understanding Drug Interactions and Individual Differences

The study highlights the need for further research to evaluate the impact of P-glycoprotein inhibition on drug efficacy and safety in individual patients. It's like carefully charting the currents and tides of the port city to ensure safe and efficient navigation. The study encourages a personalized approach to drug therapy, taking into account individual variations in drug metabolism and transport.

Dr. Camel's Conclusion

This study underscores the importance of understanding P-glycoprotein's role in drug transport and metabolism. It's a reminder that even seemingly minor variations in drug interactions can significantly influence treatment outcomes. The study encourages further research to unravel the complex interplay between drugs and P-glycoprotein, paving the way for more effective and personalized therapies.

Date :
  1. Date Completed 2003-02-12
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

12545146

DOI: Digital Object Identifier

S0009923602176120

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.